The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study

被引：0

作者：

Al Sulaiman, Khalid ^{[1
,2
,3
,4
,19
]}

Aljuhani, Ohoud ^{[5
]}

Korayem, Ghazwa B. ^{[6
]}

Altebainawi, Ali F. ^{[7
,8
]}

Vishwakarma, Ramesh ^{[9
]}

AlFaifi, Mashael ^{[10
]}

Alsohimi, Samiah ^{[11
,12
]}

Alrayes, Aljoharah ^{[6
]}

Albishi, Sara ^{[6
]}

Alqahtani, Reem ^{[6
]}

Alalawi, Mai ^{[13
,14
]}

Al Sulaihim, Ibrahim ^{[15
]}

Alanazi, Thamer A. ^{[16
]}

Alqahtani, Rahaf A. ^{[1
]}

Almagthali, Alaa ^{[12
]}

Jomah, Shahamah ^{[17
]}

Alshlowi, Areej ^{[18
]}

Alshammari, Tahani R. ^{[7
]}

Alzahrani, Shahad S. ^{[2
]}

Abdulqader, Marwa I. ^{[2
]}

机构：

[1] Pharmaceut Care Dept, King Abdulaziz Med City, Riyadh, Saudi Arabia

[2] King Saud bin Abdulaziz Univ Hlth Sci, Coll Pharm, Riyadh, Saudi Arabia

[3] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia

[4] Saudi Crit Care Pharm Res SCAPE Platform, Riyadh, Saudi Arabia

[5] King Abdulaziz Univ, Fac Pharm, Dept Pharm Practice, Jeddah, Saudi Arabia

[6] Princess Nourah bint Abdulrahman Univ, Coll Pharm, Dept Pharm Practice, Riyadh, Saudi Arabia

[7] King Salman Specialist Hosp, Pharmaceut Care Serv, Hail Hlth Cluster, Minist Hlth, Hail, Saudi Arabia

[8] Univ Hail, Coll Pharm, Dept Clin Pharm, Hail, Saudi Arabia

[9] Univ East Anglia, Norwich Med Sch, Norwich, England

[10] Pharmaceut Care Dept, King Saud Med City, Riyadh, Saudi Arabia

[11] King Fahad Armed Forces Hosp, Pharmaceut Care Serv, Jeddah, Saudi Arabia

[12] King Abdulaziz Univ Hosp, Pharmaceut Care Serv, Jeddah, Saudi Arabia

[13] Fakeeh Coll Med Sci, Dept Pharmaceut Sci, Jeddah, Saudi Arabia

[14] Pharmaceut Care Dept, King Abdulaziz Med City, Jeddah, Saudi Arabia

[15] Cent Secur Hosp, Pharmaceut Care Dept, Presidency State Secur, Riyadh, Saudi Arabia

[16] Resp Therapy Dept, King Abdulaziz Med City, Riyadh, Saudi Arabia

[17] Pharmaceut Care Dept, Dr Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia

[18] Almaarefa Univ, Coll Pharm, Dept Pharm Practice, Riyadh, Saudi Arabia

[19] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City KAMC, Minist Natl Guard Hlth Affairs MNGHA, POB 22490, Riyadh 11426, Saudi Arabia

来源：

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2023年 / 29卷

关键词：

critically ill; COVID-19; erythropoietin-stimulating agents; ESA; length of stay; mortality; ventilator-free days (VFDs);

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of ESAs on the clinical outcomes of critically ill COVID-19 patients. A multicenter, retrospective cohort study was conducted from 01-03-2020 to 31-07-2021. We included adult patients who were >= 18 years old with a confirmed diagnosis of COVID-19 infection and admitted to intensive care units (ICUs). Patients were categorized depending on ESAs administration during their ICU stay. The primary endpoint was the length of stay; other endpoints were considered secondary. After propensity score matching (1:3), the overall included patients were 120. Among those, 30 patients received ESAs. A longer duration of ICU and hospital stay was observed in the ESA group (beta coefficient: 0.64; 95% CI: 0.31-0.97; P = < .01, beta coefficient: 0.41; 95% CI: 0.12-0.69; P = < .01, respectively). In addition, the ESA group's ventilator-free days (VFDs) were significantly shorter than the control group. Moreover, patients who received ESAs have higher odds of liver injury and infections during ICU stay than the control group. The use of ESAs in COVID-19 critically ill patients was associated with longer hospital and ICU stays, with no survival benefits but linked with lower VFDs.

引用

页数：10

共 50 条

[21] Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
Al Sulaiman, Khalid A.
Aljuhani, Ohoud
Eljaaly, Khalid
Alharbi, Aisha A.
Al Shabasy, Adel M.
Alsaeedi, Alawi S.
Al Mutairi, Mashael
Badreldin, Hisham A.
Al Harbi, Shmeylan A.
Al Haji, Hussain A.
Al Zumai, Omar, I
Vishwakarma, Ramesh K.
Alkatheri, Abdulmalik
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 180 - 187
[22] The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study
Aljuhani, Ohoud
Al Sulaiman, Khalid
Korayem, Ghazwa B.
Altebainawi, Ali F.
Alsohimi, Samiah
Alqahtani, Rahaf
Alfaifi, Saeedah
Alharbi, Aisha
Alkhayrat, Azzah
Hattan, Ahmed
Albassam, Meshal
Almohammed, Omar A.
Alkeraidees, Atheer
Alonazi, Dhay A.
Alsalman, Weam F.
Aldamegh, Ghaliah
Alshahrani, Rasha
Vishwakarma, Ramesh
SCIENTIFIC REPORTS, 2024, 14 (01):
[23] Clinical Characteristics of Bloodstream Infections in Critically Ill COVID-19 Patients on Mechanical Ventilation: A Multicenter Cohort Study
Chen, C.
Sun, C.
Shen, H.
Chen, W.
Yang, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[24] Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network
Dupuis, Claire
de Montmollin, Etienne
Buetti, Niccolo
Goldgran-Toledano, Dany
Reignier, Jean
Schwebel, Carole
Domitile, Julien
Neuville, Mathilde
Ursino, Moreno
Siami, Shidasp
Ruckly, Stephane
Alberti, Corinne
Mourvillier, Bruno
Bailly, Sebastien
Laurent, Virginie
Gainnier, Marc
Souweine, Bertrand
Timsit, Jean-Francois
PLOS ONE, 2021, 16 (08):
[25] Delirium and neuropsychological outcomes in critically Ill patients with COVID-19: a cohort study
Ragheb, Jacqueline
McKinney, Amy
Zierau, Mackenzie
Brooks, Joseph
Hill-Caruthers, Maria
Iskander, Mina
Ahmed, Yusuf
Lobo, Remy
Mentz, Graciela
Vlisides, Phillip E.
BMJ OPEN, 2021, 11 (09):
[26] Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study
Ferreira, Juliana C.
Ho, Yeh-Li
Besen, Bruno Adler Maccagnan Pinheiro
Malbouisson, Luiz Marcelo Sa
Taniguchi, Leandro Utino
Mendes, Pedro Vitale
Costa, Eduardo Leite Vieira
Park, Marcelo
Daltro-Oliveira, Renato
Roepke, Roberta M. L.
Silva-Jr, Joao M.
Carmona, Maria Jose Carvalho
Carvalho, Carlos R. R.
ANNALS OF INTENSIVE CARE, 2021, 11 (01)
[27] Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
Painvin, Benoit
Guillot, Pauline
Verdier, Marie-Clemence
Gacouin, Arnaud
Maamar, Adel
INTENSIVE CARE MEDICINE, 2020, 46 (09) : 1772 - 1773
[28] Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
Benoit Painvin
Pauline Guillot
Marie-Clémence Verdier
Arnaud Gacouin
Adel Maamar
Intensive Care Medicine, 2020, 46 : 1772 - 1773
[29] Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
Emma J. Kooistra
Nicole J. B. Waalders
Inge Grondman
Nico A. F. Janssen
Aline H. de Nooijer
Mihai G. Netea
Frank L. van de Veerdonk
Esther Ewalds
Johannes G. van der Hoeven
Matthijs Kox
Peter Pickkers
Critical Care, 24
[30] Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
Kooistra, Emma J.
Waalders, Nicole J. B.
Grondman, Inge
Janssen, Nico A. F.
de Nooijer, Aline H.
Netea, Mihai G.
van de Veerdonk, Frank L.
Ewalds, Esther
van der Hoeven, Johannes G.
Kox, Matthijs
Pickkers, Peter
CRITICAL CARE, 2020, 24 (01)

← 1 2 3 4 5 →